INTRODUCTION: In Colombia, there are no published studies for the treatment of
uncomplicated Plasmodium falciparum malaria comparing artemisinin combination …

A mathematical model is developed for describing malaria transmission in a population
consisting of infants and adults and in which there are users of counterfeit antimalarial …

Most patients with suspected malaria do not receive diagnostic confirmation before
beginning antimalarial treatment. We investigated the extent to which uncertainty about …

Background Standardised checklists of items to be addressed in clinical study protocols and
publications are promoting transparency in research. However, particular specifications for …

Background: Antimalarial drug resistance has been a major contributor to the failure of the
battle against malaria in many developing countries. The P. falciparum genes, pfcrt and …

Conclusions In this systematic review, we present information relating to the effectiveness
and safety of the following interventions: amodiaquine plus sulfadoxine-pyrimethamine; …

Surveillance of Plasmodium falciparum crt (K76T)[Pf crt (K76T)], a resistance marker of
chloroquine and, limitedly, amodiaquine, in> 4,000 children in northern Ghana revealed a …

Background: The emergence of artemisinin resistance has raised concerns that the most
potent antimalarial drug may be under threat. Artesunate+ amodiaquine (ASAQ) and …

ABSTRACT A review of published clinical trials from Ghana shows the earliest trials initiated
in the 1970s, were mainly trials of interventions against onchocerciasis and childhood …

Of the plethora of parasitic diseases that afflict mankind, malaria remains the most significant
with 100-300 million cases reported annually and 600,000 fatalities. Treatment and control …